linkedin
Mishra R.Chakraborthy G. S, Agrahari R. Relationship Between Autoimmune and Metabolic Disease in Current Prospectus. Biomed Pharmacol J 2025;18(3).
Manuscript received on :18-10-2024
Manuscript accepted on :05-05-2025
Published online on: 24-07-2025
Plagiarism Check: Yes
Reviewed by: Dr. Kashif Zayan
Second Review by: Dr. Hina Imran
Final Approval by: Dr. Ian James Martin
How to Cite    |   Publication History
Views  Views: 
Visited 291 times, 1 visit(s) today
 
Downloads  PDF Downloads: 
217

Rakhi Mishra, Guno Sindhu Chakraborthy*and Rohit Agrahari

Parul Institute of Pharmacy and Research, Faculty of Pharmacy, Parul University, Vadodara, Gujarat, India

Corresponding Author E-mail: g.chakraborthy19159@paruluniversity.ac.in

DOI : https://dx.doi.org/0.13005/bpj/3223

Abstract

Stoutness is a chronic metabolic syndrome that occurs due to overeating and lack of energy expenditure in the form of any physical exercise, the indication of stoutness is being overweight, an increase in abdomen circumference, and various socioeconomic factors. Stoutness is related to multiple diseases such as hyperlipidemia, hypertension, and type 2 diabetes mellitus. The indication of stoutness is observed by elevation in body weight and increase in circumference of the abdomen. Thyroid and stoutness have similarities in them such as increased body weight and it also causes slow metabolism which causes weight gain which leads to obesity it also causes inflammation in the body which is also a major factor of obesity. This article also discusses the role of leptin in obesity and thyroid, where there is a correlation in terms of some receptors involved in them. It also contains the inflammation role in stout and thyroid dysfunction. Generally, in the thyroid, the inflammation of the thyroid gland and the neck circumference is noted, and insulin resistance is also there. A study suggested all the aspects. Due to stoutness a resistance to thyroid hormone is also studied and all the aspects suggested in the article there are also changes occur in adipose tissue which is a major factor in stoutness and is also correlated with a thyroid disorder, adipose tissue is also indirectly correlated with energy expenditure. In this article, we discuss all the possible parameters and factors that are involved in stoutness and thyroid dysfunction.

Keywords

Adipose Tissue; Hypertension; Hyperleptinemia; Inflammation; Metabolic Syndrome; Stoutness; Thyroid Dysfunction

Download this article as: 
Copy the following to cite this article:

Mishra R.Chakraborthy G. S, Agrahari R. Relationship Between Autoimmune and Metabolic Disease in Current Prospectus. Biomed Pharmacol J 2025;18(3).
Copy the following to cite this URL:

Mishra R.Chakraborthy G. S, Agrahari R. Relationship Between Autoimmune and Metabolic Disease in Current Prospectus. Biomed Pharmacol J 2025;18(3). Available from: https://bit.ly/4qaspUl

Introduction

Thyroid dysfunction is mostly associated with weight gain along with changes in body temperature, metabolism rate, expenditure of energy, intake of food, level of glucose, and lipid metabolism. Thyroid disorders, comprising autoimmune thyroid diseases (AITDs) and thyroid dysfunctions, are becoming more common these days. Hyperthyroidism and hypothyroidism are examples of thyroid dysfunctions.1 The extended effect of hypothyroidism causes severe health problems due to the essential role of thyroid hormone which restrains various parameters of physiological and assures bodily equilibrium which elevates the possibility of Dysmetabolic syndrome, reproductive health problems, and CVD.2,3,4 Thyroid disorder has very frequent occurrence in females during the reproductive period span this disorder mainly occurs due to the origin of autoimmune hyperthyroidism as being part of Grave’s disease. (GD).5 Many studies show that being overweight can elevate the thyroid gland function and majorly increase the thyrotropin collection. It also changes the content between the tri-iodothyronine and thyroxine, though within the normal range. Research indicates a favorable association between obesity and serum thyrotropin levels, which affect thyroid functions and tri-iodothyronine (T3) in Individuals euthyroid, indicating probable effect the influence of Obesity affects hypothalamic-pituitary function—Axis of thyroid and exertion of deiodinases. 6,7]Fluctuation in the Ductless gland even if they are in the normal range can exacerbate metabolic Conditions and progress the disease in the thyroid gland It is important to note in this context that components have been positively correlated with elevated TSH and T3 levels of metabolic syndrome, particularly elevated serum TSH levels have been connected to thyroid cancer risk. 8,9Consequently, taking into account the intricacy of the pathophysiology of obesity and the effects of this condition on the thyroid the main aim of this review is to bring recent information to the exact mechanisms underlying the thyroid’s alterations function in those who are stout.

Correlation between Thyroid and Stoutnesss

Nowdays, the prevalence of obesity with thyroid are growing with growing ages these are   maybe with changes in lifestyle not following the healthy lifestyle , lacking energy expenditure in term of over eating ,hormonal imbalance these are common factors through which we can correlate with stoutness and thyroid .The correlation between thyroid and stoutness are better understand by the flow chart diagram.

Figure 1: This Flow chart define the correlation of obesity with thyroid in various possible manner.Click here to view Figure 

Role of Hyperleptinemia

Generally, in stoutness, the occurrence of hyperleptinemia is a very significant factor regarding the evolution in the hypo-thalamic thyroid axis of the pituitary. It happens to control leptin, a role which is influenced by the thyrotropin and releasing hormones and gets the combination of an arcuate, nucleus (indirect route) or with a direct route which is the nucleus of the paraventricular hypothalamic region increases stimulate the hormone of thyroid production by the gland of pituitary that may approve an increased in the blood levels of this hormone in stout persons.10 In the Nucleus of the Paraventricular hypothalamic, leptin acts through a receptor of ObRb that progresses the phosphorylation of stenography factor STAT3 this pathway promotes the binding of regions which enhances the gene coding for TRH. Leptin inhibits neurons that produce Protein related to Agouti (AgRP) and activates a subset of the arcuate nucleus which is located in neurons that express proopiomelanocortin (POMC).NPJ or neuropeptide Y. This action results in higher output of the hormone Alpha melanocyte stimulating the hormone (alpha MSH), It is consequently capable of inducing hypothalamic neurons to express TRH by binding to the receptor for melanocortin 4 (MC4-R). 11,12Leptin seems to enhance the metabolic function of the hormone and thyroid by promoting the activity of a deiodinase enzyme in distinct tissue.13According to this, it’s very crucial to mention here that activity changes in enzymes mainly occur in stoutness, with activity in a brown adipose tissue D2 activity and the pituitary being shown to be reduced, and D1 activity increasing in the liver, kidney, and thyroid. 14,15 In some stout subjects high circulating leptin levels, it seems that it can also elevate the serum level of hormones such as T3 AND T4 concentrations which can show a protection against stoutness by increasing metabolic rate.16,17,18,19,20,21

Role of Inflammation

Latest scenario and experimental data suggest that a strong relation has proven the a two-directional link between obesity and thyroid disease.22.23The average incidence of thyroiditis caused by autoimmune agents and idiopathic hypothyroidism, respectively, was found to be 17.1% and 12.3% in a future study of 783 obese individuals who were mentioned to undergo bariatric surgery.24Obesity and thyroid autoimmunity have connections not just via shared pathogenetic routes but also with epidemiological attributes. A key variable in this relationship is insulin resistance (IR), which affects 15.5–46% of obese people.25Consequently, dysregulation of the insulin/leptin system, an increase in oxLDLc, and amplification of the inflammasome are all related to reduced immune response and metabolic alterations that promote thyroid autoimmunity26,27,28. Particularly, low-grade inflammation results in a spike in IL-1beta production, which plays a major role in the pathological process of Hashimoto’s thyroiditis (HT), by preferring CD4 + T helper cells over pro-inflammatory Th17 fractions29,30,31 . It is an appealing note that both rat thyroid cells and human expressing cells are TLRs present on their surface, and these receptors possess the capacity to directly bind “danger molecules” that are both endogenous and foreign, rapidly initiating the innate immune system. The hypothesis that thyroid damage to tissues is associated with the innate immune response is supported by many experimental findings. Damage to thyroid cells initiates the generation of intracellular proteins that antigen-presenting cells (APC) might identify. This stimulates the acquired immune response, which intensifies the damage to thyroid cells and ultimately results in the demise of thyroid tissue. 32,33,34Another significant element of the proposed reciprocal interaction between the thyroid immune mechanism and obesity is thyroid hormone. Any clinical condition that results in changed thyroid hormone levels could have an impact on how much the immune system and inflammation are activated. However, changes in thyroid hormone levels could be advantageous for inflammation, atherosclerosis, and obesity. According to recent research, triiodothyronine negatively affects the function of macrophages and NLR inflammatory enzymes. On the other hand, hypothyroid individuals may experience increased inflammatory and immunological responses when their thyroxine (T4) levels are low.35,36 It binds with the cell membrane and integrin receptor avβ3, T4 can also have an extra-genomic effect. This can modulate the immune response by activating signaling pathways such as mitogen-activated protein kinase (MAPK), cyclooxygenase 2 (COX-2), and hypoxia factor one alpha (HIF-1alpha), which leads to inflammasome activate.37

Causes and Changes in Adipose Tissue and Thyroid Dysfunction

Stoutness and the thyroid have a complicated and reciprocal interaction. It is widely acknowledged in the literature that dysfunction either hyper- or hypothyroidism in this gland causes variations in body weight as a result of the involvement of the hormone thyroid which regulates hunger and thermogenesis. However as recent studies have demonstrated, being overweight can also affect thyroid function when hyperthyrotropinemia is present. Irrespective of alterations in T3 and T4 levels, typically seen in stout euthyroid patients.38,39It is true that are thyroid hormone plays a significant role in controlling hunger and energy expenditure. Conversely, secretory products act on the CNS to provide information about the amount of energy reserves, and I could influence the hypothalamus-pituitary-thyroid axis’s activity. 40,41The issue is complicated, and it is made more so by the possibility that patients who are obese may have changes in the thyroid function test, which begs the question if a certain replacement procedure is recommended. According to epidemiological studies, obesity may be connected to a higher future of thyroid cancer. Even if this is connection still up for discussion, it led to a talk about the potential factors that underlie obesity’s impact on thyroid carcinogenesis. This evaluation essay seeks to evaluate pertinent information from the literature and to talk about the prevailing views on these subjects. Notably, decades of study have shown a connection between thyroid hormone concentrations and fluctuations in body weight. 42,43 When the hypothalamic-pituitary-thyroid axis regulates the adaptation of both metabolism and thermos-genesis by interacting with adipose tissue. Regulating: i) adipogenesis-related transcription factors of brown adipose tissue or white adipose tissue (WAT). (BAT); ii) genes associated with lipogenesis, or lipid metabolism and oxidation, as well as lipolysis); and iii) genes controlling BAT thermogenesis.44Thyroid hormone affects thermogenesis at the brain’s cortex level as well. The hypothalamus expresses the TR, which modifies the nervous system’s sympathetic output of the BAT 45. It helps due to the unfavorable power balance that exists in thyrotoxic conditions. Nevertheless, the primary pathway for regulating the hypothalamic-pituitary-thyroid axis in stoutness is caused by resistance selective to leptin in the arcuate nucleus of the hypothalamus via means this is adipokine’s direct impact on the paraventricular center.46,47

Inheritance to Thyroid Hormone

A hereditary disease known as inherent to thyroid hormones is indicated by a decrease in the affinity of thyroid receptor ligands for T3, which is linked to an irreversible interaction of receptor co-repressors. The most prevalent type entails β receptors (TRβ) mutations marked by increased T3 levels in the serum and T4, as well as normal and slightly elevated TSH levels. And the other hand, α receptor (TRα) degradation encourages an increase in TSH, and T4 continues to be normal in serum T3, whereas T3 is linked to elevated BMI and cholesterol.[48].Extensive research has been carried out on resistance to TH (RTH), a disease wherein TRβ demonstrates a reduced capacity of binding T3 or corepressor binding remains unopposed through ligands 49. The Patients usually show slightly higher serum TSH levels but are “inappropriately normal” or elevated blood T4 and T3 concerns. This is because the faulty TRβ prevents, elevated blood T4 or T3 concentrations from suppressing TSH. With one exception of tachycardia, the accompanying clinical features—goiter and overall euthyroid—are consistent with the high blood T4 and T3 triggering TRα in the atria without interference. Additional clinical characteristics that differ between afflicted parties include decreased linear development, deafness, irregularities in the development of bones, and attention deficit disorder.50

Interrelation between thyroid cancer and Body weight

The earliest research that is now available to the 1940s, and It link between obesity and cancer has been studied for a very long time. During the decade of 1987, the Ist recorded stoutness increase was seen, Albanes51. Association regarding the relation between stoutness and thyroid cancer, there are two kinds of observational studies: the first looks for the future of thyroid cancer in stout patients, while the second looks for obesity in thyroid cancer patients. While there is no proof that thyroid cancer causes significant metabolic changes, it is significant to note that stoutness can be an epiphenomenon of the disease. As a result, the second type of study is less relevant. These approaches provide different information and images. The majority of observational research cited in this version involves sizable cohorts of individuals who are obese. 52.Examined Twelve case-control studies conducted in 1990, involving 2056 females or 417 men with thyroid cancer. The results showed that there was no correlation, although a weak one, between the Body mass index at diagnosis and a higher risk of thyroid cancer in females (OR=1.2). Although other writers have demonstrated links between food consumption and the risk of thyroid cancer53. This first assessment focused solely on anthropometric parameters; it excluded information on eating patterns or other potential risk factors for obesity and cancer. Still, it offered the justification for more research. There wasn’t much research at the time concentrating on the processes of thyroid tumors linked to obesity. [54] Thyroid nodules and the thyroid volume are associated directly with body mass index. According to this association, there is also a correlation with insulin resistance. 55

Energy Expenditure and Adipose Tissue

A continuous energy source is necessary for all living things to maintain the stability of their internal environments. Energy-producing substances, primarily fatty acids, and carbs, are collected from the surroundings and kept in storage to provide accessibility in case of malnourishment. To maintain Homoeostasis of energy, supply, and consumption must be maintained in equilibrium. A relative surplus of energy is produced as a result of either a rise in energy consumption or a fall in energy usage, which is obesity’s root cause. The difficulty Scientists and physicians must work to restore equilibrium in a setting that makes individuals more vulnerable to an energy excess. Although constraint can restore equilibrium Increasing energy expenditure is also a function of energy intake aim56. When Brown adipose tissue (BAT) offers a physio-logical model that enables quick increases in energy expenditure, such as during the arousal of a wintering mammal. It is a discovery that BAT in mature human beings implies that recognizing or pursuing methods to increase BAT energy consumption aids in helping obese persons regain their energy balance. This Examines how thyroid hormone signaling is examined in Thermal genesis triggered by BAT; and investigates the relationship between type 2 deiodinase (D2) and BAT. The D2 is an important BAT function regulation and protein-uncoupling -1 (Ucp1) induction and is required for the appropriate growth of BAT or brown adipocyte differentiation. D2- Adults can express BAT, and recent findings of Its application in physiology and medicine could grow this area of expertise. 56Unlike white adipose tissue, which generally stores and discharges energy in response to the demand of systemic, brain-associated tissue (BAT) specialist tissue that energy by producing heating. It is a distinct function that the white and brown adipose tissue sustain and also visible the differences in their structures—BAT has thick mitochondrial content, has a robust innervation pattern. While sympathetic fibers are heavily vascularized, There are few mitochondria in white adipose tissue, and it is significantly less vascularized and innervated. Mitochondrial Ucp1, a 32 kDa protein, mediates uncoupling on BAT. Expressed in mitochondria’s inner membrane, it eliminates the inner proton gradient mitochondrial membrane that is not phosphorylated with ADP.4 57 The global obesity crisis has increased the importance of comprehending the relationship between thyroid hormone metabolism or BAT function. Currently, obesity treatment aims to lessen power input or raise power use or gratuity to the equilibrium toward the overall body-energy deficit. The majority of obesity treatment strategies emphasize increased physical exercise, which patients find challenging to effectively follow, raising energy consumption is a difficult therapeutic objective. Thus, the application of in BAT, thyroid-hormone signaling plays a crucial different therapeutic objective. 56A prime example of this is the impact of cold exposure on the brown adipose tissue (BAT). Type 2 deiodinase drives a temporary condition of “cellular hyperthyroidism,” which is brought on by activation of the beta 3-adrenergic pathway. Therefore, UCP-1 transcription or mitochondrial membrane permeability was selectively enhanced. , which in turn causes a dissociation between ATP production and mitochondrial respiration. This ultimately promotes a dissociation between ATP production and mitochondrial respiration, leading to an ultra-efficient and timely generation of heat to maintain the core of temperature.TH activity is regulated at the cellular level of a class by enzymes that comprise Selena proteins. There are three enzymes, only type 2 and type 1deiodinase can convert prohormone T4 to active TH T3, allowing for variations in local concern and regulating the hormone action on specific tissues without significantly altering blood levels. With a strong affinity for T4, type two deiodinase is mostly located in the brain, gland of the pituitary, thyroid, muscle, and brown fat. It plays a significant role in the tissue- and time-specific control of thyroid hormone action during thermogenesis.

Role of Hormones of thyroid in Regulating SIRT1

Thyroid hormones are not only integral to metabolic regulation but also to gene which expression are modulating. There is a key gene which is influenced by signaling of thyroid hormone is Sirtuin 1 (SIRT1) , which is a NAD+ – dependent deacetylase which known for its anti-aging, anti-inflammatory and metabolic regulatory functions. Various emerging evidence suggests that SIRT1 is essential in mitigating autoimmune responses, which also enhance the metabolic balance. Dysregulation of this occurs due to hypothyroidism which suspected to contribute to onset progression of autoimmune diseases and metabolic disorders 57. A study also emphasizes the role of SIRT1 ,in regulation to appetite and reversing cellular senescence and apoptosis- processes intricately linked with thyroid hormone functions and particularly in metabolic and endocrine balance, there is also correlation between lipid and glucose metabolism with thyroid hormone ,as it plays a important role in this metabolism , this also suggest a indirect connection via share regulatory genes like SIRT1 58,59 .

Conclusion

In the future there is a correlation between thyroid dysfunction and stoutness is registered in all aspects such as in terms of inflammation, adipose tissue, and resistance this disease will show a high impact on the population in the coming years, and usually various studies have been conducted and the study suggested that the prevalence of this disease correlation will become very high in developing countries. In this article the flow chart is also attached which will give more insights about the relationship between thyroid and stoutness in coming year the belief in correlation between these two disease will give remarkable significance and hence the treatment approaches will also get enhanced .Thus, the thyroid hormone status may indirectly influence disease susceptibility through its epigenetic control of SIRT1. This article discusses all the major factors through which we can treat and resist the disease’s commencement.

Acknowledgement

The authors are thankful to provide all the faculties in Parul Institute of pharmacy and research and Department of Pharmacy (pharmacology), Parul University for their Support.

Funding Sources

The author(s) received no financial support for the research, authorship, and/or publication of this article.

Conflict of Interest

The author(s) do not have any conflict of interest.

Data Availability Statement

This statement does not apply to this article.

Ethics Statement

This research did not involve human participants, animal subjects, or any material that requires ethical approval.

Informed Consent Statement

This study did not involve human participants, and therefore, informed consent was not required.

Clinical Trial Registration

This research does not involve any clinical trials

Permission to reproduce material from other sources

Not applicable

Author contributions

Guno Sindhu: Analysis, Supervision, Resources

Rakhi Mishra: Review & Editing, Data Collection.

Rohit Agrahari: – Review & Editing, Data Collection

Reference

  1. Taylor PN, Albrecht D, Scholz A, Gutierrez-Buey G, Lazarus JH, Dayan CM, Okosieme OE. Global epidemiology of hyperthyroidism and hypothyroidism. Nat Rev Endocrinol. 2018;14(5):301-316. doi:10.1038/nrendo.2018.18
    CrossRef
  2. Dugbartey AT. Neurocognitive Aspects of Hypothyroidism. Arch Intern Med. 1998;158(13):1413. doi:10.1001/archinte.158.13.1413
    CrossRef
  3. Biondi B, Klein I. Hypothyroidism as a Risk Factor for Cardiovascular Disease. Endocrine. 2004;24(1):001-014. doi:10.1385/ENDO:24:1:001
    CrossRef
  4. Su X, Peng H, Chen X, Wu X, Wang B. Hyperlipidemia and hypothyroidism. ClinicaChimicaActa. 2022;527:61-70. doi:10.1016/j.cca.2022.01.006
    CrossRef
  5. Carlé A, Pedersen IB, Knudsen N, Perrild H, Ovesen L, Rasmussen LB, Laurberg P. Epidemiology of subtypes of hyperthyroidism in Denmark: a population-based study. Eur J Endocrinol. 2011;164(5):801-809. doi:10.1530/EJE-10-1155
    CrossRef
  6. Bétry C, Challan-Belval MA, Bernard A, Charrié A, Drai J, Laville M, Thivolet C, Disse E. Increased TSH in obesity: Evidence for a BMI-independent association with leptin. Diabetes Metab. 2015;41(3):248-251. doi:10.1016/j.diabet.2014.11.009
    CrossRef
  7. Ren R, Jiang X, Zhang X, Guan Q, Yu C, Li Y, Gao L, Zhang H, Zhao J. Association between thyroid hormones and body fat in euthyroid subjects. ClinEndocrinol (Oxf). 2014;80(4):585-590. doi:10.1111/cen.12311
    CrossRef
  8. Marcello MA, Cunha LL, Batista FA, Ward LS. Obesity and thyroid cancer. Endocrine Related Cancer. 2014;21(5):T255-T271. doi:10.1530/ERC-14-0070
    CrossRef
  9. Wang X, Liu H, Chen J, Huang Y, Li L, Rampersad S, Qu S. Metabolic Characteristics in Obese Patients Complicated by Mild Thyroid Hormone Deficiency. Hormone and Metabolic Research. 2016;48(05):331-337. doi:10.1055/s-0042-105150
    CrossRef
  10. Ghamari-Langroudi M, Vella KR, Srisai D, Sugrue ML, Hollenberg AN, Cone RD. Regulation of Thyrotropin-Releasing Hormone-Expressing Neurons in Paraventricular Nucleus of the Hypothalamus by Signals of Adiposity. Molecular Endocrinology. 2010;24(12):2366-2381. doi:10.1210/me.2010-0203
    CrossRef
  11. Hollenberg AN. The Role of the Thyrotropin-Releasing Hormone (TRH) Neuron as a Metabolic Sensor. Thyroid. 2008;18(2):131-139. doi:10.1089/thy.2007.0251
    CrossRef
  12. van de Sande-Lee S, Velloso LA. Disfunçãohipotalâmicanaobesidade. ArquivosBrasileiros de Endocrinologia&Metabologia. 2012;56(6):341-350. doi:10.1590/S0004-27302012000600001
    CrossRef
  13. Cabanelas A, Lisboa P, Moura E, Pazos-Moura C. Acute Effects of Leptin on 5′-Deiodinases are Modulated by Thyroid State of Fed Rats. Hormone and Metabolic Research. 2007;39(11):818-822. doi:10.1055/s-2007-991169
    CrossRef
  14. Araujo RL, Andrade BM, Padrón AS, Gaidhu MP, Perry RLS, Carvalho DP, Ceddia RB. High-Fat Diet Increases Thyrotropin and Oxygen Consumption without Altering Circulating 3,5,3′-Triiodothyronine (T3) and Thyroxine in Rats: The Role of IodothyronineDeiodinases, Reverse T3 Production, and Whole-Body Fat Oxidation. Endocrinology. 2010;151(7):3460-3469. doi:10.1210/en.2010-0026
    CrossRef
  15. Landa MS, García SI, Schuman ML, Burgueño A, Alvarez AL, Saravia FE, Gemma C, Pirola CJ. Knocking down the diencephalicthyrotropin-releasing hormone precursor gene normalizes obesity-induced hypertension in the rat. American Journal of Physiology-Endocrinology and Metabolism. 2007;292(5):E1388-E1394. doi:10.1152/ajpendo.00234.2006
    CrossRef
  16. Tagliaferri M, Berselli ME, Calò G, Minocci A, Savia G, Petroni ML, Viberti GC, Liuzzi A. Subclinical Hypothyroidism in Obese Patients: Relation to Resting Energy Expenditure, Serum Leptin, Body Composition, and Lipid Profile. Obes Res. 2001;9(3):196-201. doi:10.1038/oby.2001.21
    CrossRef
  17. Knudsen N, Laurberg P, Rasmussen LB, Bülow I, Perrild H, Ovesen L, Jørgensen T. Small Differences in Thyroid Function May Be Important for Body Mass Index and the Occurrence of Obesity in the Population. J ClinEndocrinolMetab. 2005;90(7):4019-4024. doi:10.1210/jc.2004-2225
    CrossRef
  18. De Pergola G, Ciampolillo A, Paolotti S, Trerotoli P, Giorgino R. Free triiodothyronine and thyroid stimulating hormone are directly associated with waist circumference, independently of insulin resistance, metabolic parameters and blood pressure in overweight and obese women. ClinEndocrinol (Oxf). 2007;67(2):265-269. doi:10.1111/j.1365-2265.2007.02874.x
    CrossRef
  19. Pelletier P, Gauthier K, Sideleva O, Samarut J, Silva JE. Mice Lacking the Thyroid Hormone Receptor-α Gene Spend More Energy in Thermogenesis, Burn More Fat, and Are Less Sensitive to High-Fat Diet-Induced Obesity. Endocrinology. 2008;149(12):6471-6486. doi:10.1210/en.2008-0718
    CrossRef
  20. Reinehr T, Isa A, de Sousa G, Dieffenbach R, Andler W. Thyroid Hormones and Their Relation to Weight Status. Horm Res Paediatr. 2008;70(1):51-57. doi:10.1159/000129678
    CrossRef
  21. Weetman AP. An update on the pathogenesis of Hashimoto’s thyroiditis. J Endocrinol Invest. 2021;44(5):883-890. doi:10.1007/s40618-020-01477-1
    CrossRef
  22. Biondi B. Thyroid and Obesity: An Intriguing Relationship. J ClinEndocrinolMetab. 2010;95(8):3614-3617. doi:10.1210/jc.2010-1245
    CrossRef
  23. Fierabracci P, Pinchera A, Martinelli S, Scartabelli G, Salvetti G, Giannetti M, Pucci A, Galli G, Ricco I, Querci G, Rago T, Di Salvo C, Anselmino M, Vitti P, Santini F. Prevalence of Endocrine Diseases in Morbidly Obese Patients Scheduled for Bariatric Surgery: Beyond Diabetes. Obes Surg. 2011;21(1):54-60. doi:10.1007/s11695-010-0297-6
    CrossRef
  24. Fahed M, AbouJaoudeh MG, Merhi S, Mosleh JMB, Ghadieh R, Al Hayek S, El Hayek Fares JE. Evaluation of risk factors for insulin resistance: a cross sectional study among employees at a private university in Lebanon. BMC EndocrDisord. 2020;20(1):85. doi:10.1186/s12902-020-00558-9
    CrossRef
  25. Duntas LH, Biondi B. The Interconnections Between Obesity, Thyroid Function, and Autoimmunity: The Multifold Role of Leptin. Thyroid. 2013;23(6):646-653. doi:10.1089/thy.2011.0499
    CrossRef
  26. Yang CA, Chiang BL. Inflammasomes and human autoimmunity: A comprehensive review. J Autoimmun. 2015;61:1-8. doi:10.1016/j.jaut.2015.05.001
    CrossRef
  27. Santini F, Marzullo P, Rotondi M, Ceccarini G, Pagano L, Ippolito S, Chiovato L, Biondi B. MECHANISMS IN ENDOCRINOLOGY: The crosstalk between thyroid gland and adipose tissue: signal integration in health and disease. Eur J Endocrinol. 2014;171(4):R137-R152. doi:10.1530/EJE-14-0067
    CrossRef
  28. Mollaei M, Abbasi A, Hassan ZM, Pakravan N. The intrinsic and extrinsic elements regulating inflammation. Life Sci. 2020;260:118258. doi:10.1016/j.lfs.2020.118258
    CrossRef
  29. Guo Q, Wu Y, Hou Y, Liu Y, Liu T, Zhang H, Fan C, Guan H, Li Y, Shan Z, Teng W. Cytokine Secretion and Pyroptosis of Thyroid Follicular Cells Mediated by Enhanced NLRP3, NLRP1, NLRC4, and AIM2 Inflammasomes Are Associated With Autoimmune Thyroiditis. Front Immunol. 2018;9. doi:10.3389/fimmu.2018.01197
    CrossRef
  30. Hepp M, Werion A, De Greef A, de Ville de Goyet C, de Bournonville M, Behets C, Lengelé B, Daumerie C, Mourad M, Ludgate M, Many MC, Joris V, Craps J. Oxidative Stress-Induced Sirtuin1 Downregulation Correlates to HIF-1α, GLUT-1, and VEGF-A Upregulation in Th1 Autoimmune Hashimoto’s Thyroiditis. Int J Mol Sci. 2021;22(8):3806. doi:10.3390/ijms22083806
    CrossRef
  31. De Luca R, Davis PJ, Lin HY, Gionfra F, Percario ZA, Affabris E, Pedersen JZ, Marchese C, Trivedi P, Anastasiadou E, Negro R, Incerpi S. Thyroid Hormones Interaction With Immune Response, Inflammation and Non-thyroidal Illness Syndrome. Front Cell Dev Biol. 2021;8. doi:10.3389/fcell.2020.614030
    CrossRef
  32. Ishii KJ, Suzuki K, Coban C, Takeshita F, Itoh Y, Matoba H, Kohn LD, Klinman DM. Genomic DNA Released by Dying Cells Induces the Maturation of APCs . The Journal of Immunology. 2001;167(5):2602-2607. doi:10.4049/jimmunol.167.5.2602
    CrossRef
  33. Evavold CL, Ruan J, Tan Y, Xia S, Wu H, Kagan JC. The Pore-Forming Protein Gasdermin D Regulates Interleukin-1 Secretion from Living Macrophages. Immunity. 2018;48(1):35-44.e6. doi:10.1016/j.immuni.2017.11.013
    CrossRef
  34. De Vito P, Incerpi S, Pedersen JZ, Luly P, Davis FB, Davis PJ. Thyroid Hormones as Modulators of Immune Activities at the Cellular Level. Thyroid. 2011;21(8):879-890. doi:10.1089/thy.2010.0429
    CrossRef
  35. Kwakkel J, Surovtseva OV, de Vries EM, Stap J, Fliers E, Boelen A. A Novel Role for the Thyroid Hormone-Activating Enzyme Type 2 Deiodinase in the Inflammatory Response of Macrophages. Endocrinology. 2014;155(7):2725-2734. doi:10.1210/en.2013-2066
    CrossRef
  36. De Vito P, Balducci V, Leone S, Percario Z, Mangino G, Davis PJ, Davis FB, Affabris E, Luly P, Pedersen JZ, Incerpi S. Nongenomic effects of thyroid hormones on the immune system cells: New targets, old players. Steroids. 2012;77(10):988-995. doi:10.1016/j.steroids.2012.02.018
    CrossRef
  37. Pearce EN. Thyroid hormone and obesity. CurrOpinEndocrinol Diabetes Obes. 2012;19(5):408-413. doi:10.1097/MED.0b013e328355cd6c
    CrossRef
  38. Santini F, Marzullo P, Rotondi M, Ceccarini G, Pagano L, Ippolito S, Chiovato L, Biondi B. MECHANISMS IN ENDOCRINOLOGY: The crosstalk between thyroid gland and adipose tissue: signal integration in health and disease. Eur J Endocrinol. 2014;171(4):R137-R152. doi:10.1530/EJE-14-0067
    CrossRef
  39. Rotondi M, Magri F, Chiovato L. Thyroid and Obesity: Not a One-Way Interaction. J ClinEndocrinolMetab. 2011;96(2):344-346. doi:10.1210/jc.2010-2515
    CrossRef
  40. Duntas LH, Biondi B. The Interconnections Between Obesity, Thyroid Function, and Autoimmunity: The Multifold Role of Leptin. Thyroid. 2013;23(6):646-653. doi:10.1089/thy.2011.0499
    CrossRef
  41. Bjergved L, Jørgensen T, Perrild H, Laurberg P, Krejbjerg A, Ovesen L, Rasmussen LB, Knudsen N. Thyroid Function and Body Weight: A Community-Based Longitudinal Study. PLoS One. 2014;9(4):e93515. doi:10.1371/journal.pone.0093515
    CrossRef
  42. Obregon MJ. Thyroid Hormone and Adipocyte Differentiation. Thyroid. 2008;18(2):185-195. doi:10.1089/thy.2007.0254
    CrossRef
  43. López M, Varela L, Vázquez MJ, Rodríguez-Cuenca S, González CR, Velagapudi VR, Morgan DA, Schoenmakers E, Agassandian K, Lage R, de Morentin PBM, Tovar S, Nogueiras R, Carling D, Lelliott C, Gallego R, Orešič M, Chatterjee K, Saha AK, Rahmouni K, Diéguez C, Vidal-Puig A. Hypothalamic AMPK and fatty acid metabolism mediate thyroid regulation of energy balance. Nat Med. 2010;16(9):1001-1008. doi:10.1038/nm.2207
    CrossRef
  44. Enriori PJ, Evans AE, Sinnayah P, Jobst EE, Tonelli-Lemos L, Billes SK, Glavas MM, Grayson BE, Perello M, Nillni EA, Grove KL, Cowley MA. Diet-Induced Obesity Causes Severe but Reversible Leptin Resistance in ArcuateMelanocortin Neurons. Cell Metab. 2007;5(3):181-194. doi:10.1016/j.cmet.2007.02.004
    CrossRef
  45. Nillni EA. Regulation of ProhormoneConvertases in Hypothalamic Neurons: Implications for ProThyrotropin-Releasing Hormone and Proopiomelanocortin. Endocrinology. 2007;148(9):4191-4200. doi:10.1210/en.2007-0173
    CrossRef
  46. Mullur R, Liu YY, Brent GA. Thyroid Hormone Regulation of Metabolism. Physiol Rev. 2014;94(2):355-382. doi:10.1152/physrev.00030.2013
    CrossRef
  47. Refetoff S. Resistance to thyroid hormone: one of several defects causing reduced sensitivity to thyroid hormone. Nat ClinPractEndocrinolMetab. 2008;4(1):1-1. doi:10.1038/ncpendmet0703
    CrossRef
  48. Refetoff S, Dumitrescu AM. Syndromes of reduced sensitivity to thyroid hormone: genetic defects in hormone receptors, cell transporters and deiodination. Best Pract Res ClinEndocrinolMetab. 2007;21(2):277-305. doi:10.1016/j.beem.2007.03.005
    CrossRef
  49. Albanes D. Caloric intake, body weight, and cancer: A review. Nutr Cancer. 1987;9(4):199-217. doi:10.1080/01635588709513929
    CrossRef
  50. Maso LD, Vecchia C La, Franceschi S, Preston-Martin S, Ron E, Levi F, Mack W, Mark SD, McTiernan A, Kolonel L, Mabuchi K, Jin F, Wingren G, Galanti MR, Hallquist A, Glattre E, Lund E, Linos D, Negri E. ds. Cancer Causes and Control. 2000;11(2):137-144. doi:10.1023/A:1008938520101
    CrossRef
  51. Franceschi S, Talamini R, Fassina A, Bidoli E. Diet and Epithelial Cancer of the Thyroid Gland. Tumori Journal. 1990;76(4):331-338. doi:10.1177/030089169007600406
    CrossRef
  52. Franceschi S, Levi F, Negri E, Fassina A, La Vecchia C. Diet and thyroid cancer: A pooled analysis of four european case‐control studies. Int J Cancer. 1991;48(3):395-398. doi:10.1002/ijc.2910480315
    CrossRef
  53. Bianco AC, McAninch EA. The role of thyroid hormone and brown adipose tissue in energy homeostasis. Lancet Diabetes Endocrinol. 2013;1(3):250-258. doi:10.1016/S2213-8587(13)70069-X
    CrossRef
  54. Nicholls DG. The physiological regulation of uncoupling proteins. BiochimicaetBiophysicaActa (BBA) – Bioenergetics. 2006;1757(5-6):459-466. doi:10.1016/j.bbabio.2006.02.005
    CrossRef
  55. Ukropec J, Anunciado RP, Ravussin Y, Hulver MW, Kozak LP. UCP1-independent Thermogenesis in White Adipose Tissue of Cold-acclimated Ucp1-/- Mice. Journal of Biological Chemistry. 2006;281(42):31894-31908. doi:10.1016/S0021-9258(19)84104-2
    CrossRef
  56. Yavuz S, Salgado Nunez del Prado S, Celi FS. Thyroid Hormone Action and Energy Expenditure. J Endocr Soc. 2019;3(7):1345-1356. doi:10.1210/js.2018-00423.
    CrossRef
  57. Gathercole LL, Lavery GG, Morgan SA, Cooper MS, Sinclair AJ, Tomlinson JW, Stewart PM. 11β-Hydroxysteroid dehydrogenase 1: translational and therapeutic aspects. Endocrine reviews. 2013 Aug 1;34(4):525-55.
    CrossRef
  58. Martins IJ. Anti-aging genes improve appetite regulation and reverse cell senescence and apoptosis in global populations.
  59. Martins IJ. Nutrition therapy regulates caffeine metabolism with relevance to NAFLD and induction of type 3 diabetes. J Diabetes Metab Disord. 2017;4(1):1-9.
    CrossRef
Share Button
Visited 291 times, 1 visit(s) today

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.